251 related articles for article (PubMed ID: 32332062)
1. Modeling infectious disease dynamics.
Cobey S
Science; 2020 May; 368(6492):713-714. PubMed ID: 32332062
[No Abstract] [Full Text] [Related]
2. Surviving COVID-19: A disease tolerance perspective.
Ayres JS
Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
[No Abstract] [Full Text] [Related]
3. The 2019 human coronavirus: Ten areas of uncertainty waiting to be resolved.
Mortimer PP
Rev Med Virol; 2020 Jul; 30(4):e2114. PubMed ID: 32394505
[No Abstract] [Full Text] [Related]
4. PDA Responds to the Novel Coronavirus Situation.
Johnson RM
PDA J Pharm Sci Technol; 2020; 74(2):170. PubMed ID: 32273432
[No Abstract] [Full Text] [Related]
5. Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.
Xu W; Wang M; Yu D; Zhang X
Front Immunol; 2020; 11():565278. PubMed ID: 33013929
[TBL] [Abstract][Full Text] [Related]
6. COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies.
Bergmann CC; Silverman RH
Cleve Clin J Med; 2020 Jun; 87(6):321-327. PubMed ID: 32366502
[No Abstract] [Full Text] [Related]
7. The 'bat man' tackles COVID-19.
Kupferschmidt K
Science; 2020 Oct; 370(6512):20-21. PubMed ID: 33004495
[No Abstract] [Full Text] [Related]
8. [COVID-19- what have we learned and where are we heading?].
Gudnason T
Laeknabladid; 2020 Oct; 106(10):449. PubMed ID: 32991305
[No Abstract] [Full Text] [Related]
9. [Not Available].
Fumeaux T
Rev Med Suisse; 2020 Nov; 16(714):2190. PubMed ID: 33174705
[No Abstract] [Full Text] [Related]
10. Understanding COVID-19 vaccine efficacy.
Lipsitch M; Dean NE
Science; 2020 Nov; 370(6518):763-765. PubMed ID: 33087460
[No Abstract] [Full Text] [Related]
11. Strategies to trace back the origin of COVID-19.
Zhang X; Chen X; Zhang Z; Roy A; Shen Y
J Infect; 2020 Jun; 80(6):e39-e40. PubMed ID: 32277970
[No Abstract] [Full Text] [Related]
12. [Not Available].
Meylan P
Rev Med Suisse; 2020 Nov; 16(714):2190-2191. PubMed ID: 33174706
[No Abstract] [Full Text] [Related]
13. Emergence of a novel human coronavirus threatening human health.
Poon LLM; Peiris M
Nat Med; 2020 Mar; 26(3):317-319. PubMed ID: 32108160
[TBL] [Abstract][Full Text] [Related]
14. [Origin of SARS-CoV-2 theories, keys and unknowns of an emerged disease.].
Estévez Reboredo RM
Rev Esp Salud Publica; 2020 Sep; 94():. PubMed ID: 32994390
[TBL] [Abstract][Full Text] [Related]
15. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV.
Lee PI; Hsueh PR
J Microbiol Immunol Infect; 2020 Jun; 53(3):365-367. PubMed ID: 32035811
[No Abstract] [Full Text] [Related]
16. [Not Available].
Meylan P
Rev Med Suisse; 2020 Apr; 16(N° 691-2):875. PubMed ID: 32348057
[No Abstract] [Full Text] [Related]
17. Host Immune Response Driving SARS-CoV-2 Evolution.
Wang R; Hozumi Y; Zheng YH; Yin C; Wei GW
Viruses; 2020 Sep; 12(10):. PubMed ID: 32992592
[TBL] [Abstract][Full Text] [Related]
18. Modeling Contact Tracing Strategies for COVID-19 in the Context of Relaxed Physical Distancing Measures.
Bilinski A; Mostashari F; Salomon JA
JAMA Netw Open; 2020 Aug; 3(8):e2019217. PubMed ID: 32821920
[TBL] [Abstract][Full Text] [Related]
19. Polymorphic cutaneous manifestations of COVID-19 infection in a single viral host.
Patel N; Kho J; Smith KE; Ahmed A; Van den Abbeele K; Mandal AKJ; Missouris CG
Int J Dermatol; 2020 Sep; 59(9):1149-1150. PubMed ID: 32686096
[No Abstract] [Full Text] [Related]
20. COVID-19: Why Declining Biodiversity Puts Us at Greater Risk for Emerging Infectious Diseases, and What We Can Do.
Khetan AK
J Gen Intern Med; 2020 Sep; 35(9):2746-2747. PubMed ID: 32588178
[No Abstract] [Full Text] [Related]
[Next] [New Search]
